Change - Announcement of Cessation::Announcement of Cessation of Group Chief Executive Officer

Issuer & Securities

Issuer/ Manager
VICPLAS INTERNATIONAL LTD
Securities
VICPLAS INTERNATIONAL LTD - SG1G57870584 - 569
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
19-Jan-2022 07:14:15
Status
New
Announcement Sub Title
Announcement of Cessation of Group Chief Executive Officer
Announcement Reference
SG220119OTHRS3YB
Submitted By (Co./ Ind. Name)
Esther Au
Designation
Secretary
Description (Please provide a detailed description of the event in the box below)
Announcement of Cessation of Group Chief Executive Officer

Additional Details

Name Of Person
Cheng Liang
Age
66
Is effective date of cessation known?
Yes
If yes, please provide the date
01/08/2022
Detailed Reason (s) for cessation
Part of Vicplas Group succession plan
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
01/11/2018
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
3
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
0
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Group Chief Executive Officer
Role and responsibilities
Overall management of the Group
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Mr Cheng's son, Cheng Hsheng @ Zhang Zixian, was appointed as Acting Group Operations Director in April 2015 and assumed the permanent role as Group Operations Director in April 2016.
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Direct interest - 14,029,497 ordinary shares
Deemed interest - 9,938,000 ordinary shares
Direct interest - 2,500,000 options
Past (for the last 5 years)
None
Present
Forefront Investment Pte. Ltd.
Forefront Medical Investment Pte. Ltd.
Forefront Medical Technology (Pte) Ltd.
Rimplas Industries Sdn. Bhd.
Vicplas Holdings Pte. Ltd.
Vicplas Investment Pte. Ltd.
V & H Investment Co., Ltd.
XentiQ (Pte.) Ltd.
Forefront Medical Technology (Jiangsu) Co., Ltd
Forefront (Xiamen) Medical Devices Co., Ltd